99 related articles for article (PubMed ID: 16949670)
21. Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Hara A; Hu R; Li G; Li Y; Nakamura K; Gonzalez FJ; Aoyama T
Biochem Pharmacol; 2008 Jul; 76(1):108-19. PubMed ID: 18486101
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.
Reynders V; Loitsch S; Steinhauer C; Wagner T; Steinhilber D; Bargon J
Respir Res; 2006 Jul; 7(1):104. PubMed ID: 16875506
[TBL] [Abstract][Full Text] [Related]
23. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
24. Genetic deletion of Trb3, the mammalian Drosophila tribbles homolog, displays normal hepatic insulin signaling and glucose homeostasis.
Okamoto H; Latres E; Liu R; Thabet K; Murphy A; Valenzeula D; Yancopoulos GD; Stitt TN; Glass DJ; Sleeman MW
Diabetes; 2007 May; 56(5):1350-6. PubMed ID: 17303803
[TBL] [Abstract][Full Text] [Related]
25. Estradiol induces type 8 17beta-hydroxysteroid dehydrogenase expression: crosstalk between estrogen receptor alpha and C/EBPbeta.
Rotinen M; Celay J; Alonso MM; Arrazola A; Encio I; Villar J
J Endocrinol; 2009 Jan; 200(1):85-92. PubMed ID: 18852215
[TBL] [Abstract][Full Text] [Related]
26. Insulin regulates TRB3 and other stress-responsive gene expression through induction of C/EBPbeta.
Du K; Ding J
Mol Endocrinol; 2009 Apr; 23(4):475-85. PubMed ID: 19164449
[TBL] [Abstract][Full Text] [Related]
27. Regulation of C/EBPbeta mRNA expression and C/EBPbeta promoter activity by protein kinases A and C in a myelomonocytic cell line (HD11).
Goethe R; Basler T; Phi-van L
Inflamm Res; 2007 Jul; 56(7):274-81. PubMed ID: 17659432
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional cooperation between NF-kappaB p50 and CCAAT/enhancer binding protein beta regulates Nur77 transcription in Leydig cells.
El-Asmar B; Giner XC; Tremblay JJ
J Mol Endocrinol; 2009 Feb; 42(2):131-8. PubMed ID: 18996961
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen.
Jeong S; Yoon M
Obesity (Silver Spring); 2007 Jun; 15(6):1430-40. PubMed ID: 17557980
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of TRB3 in muscle alters muscle fiber type and improves exercise capacity in mice.
An D; Lessard SJ; Toyoda T; Lee MY; Koh HJ; Qi L; Hirshman MF; Goodyear LJ
Am J Physiol Regul Integr Comp Physiol; 2014 Jun; 306(12):R925-33. PubMed ID: 24740654
[TBL] [Abstract][Full Text] [Related]
32. Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR-alpha.
Martinsen TC; Bakke I; Chen D; Sandvik AK; Zahlsen K; Aamo T; Waldum HL
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1052-60. PubMed ID: 16099866
[TBL] [Abstract][Full Text] [Related]
33. Factors modulating fibrates response: therapeutic implications and alternative strategies.
Panadero MI; González MC; Herrera E; Bocos C
Endocr Metab Immune Disord Drug Targets; 2009 Sep; 9(3):219-36. PubMed ID: 19594420
[TBL] [Abstract][Full Text] [Related]
34. C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation.
van der Krieken SE; Popeijus HE; Konings M; Dullens SP; Mensink RP; Plat J
J Cell Biochem; 2017 Apr; 118(4):754-763. PubMed ID: 27618583
[TBL] [Abstract][Full Text] [Related]
35. [Effect of fibrates on lipid metabolism and the blood coagulation system].
Paragh G; Balogh Z
Orv Hetil; 2000 Jan; 141(1):23-6. PubMed ID: 10673854
[TBL] [Abstract][Full Text] [Related]
36. Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future.
van Raalte DH; Li M; Pritchard PH; Wasan KM
Pharm Res; 2004 Sep; 21(9):1531-8. PubMed ID: 15497675
[TBL] [Abstract][Full Text] [Related]
37. Fibrates inhibit aldose reductase activity in the forward and reverse reactions.
Balendiran GK; Rajkumar B
Biochem Pharmacol; 2005 Nov; 70(11):1653-63. PubMed ID: 16226225
[TBL] [Abstract][Full Text] [Related]
38. Statins, fibrates and retinoic acid upregulate mitochondrial acylcarnitine carrier gene expression.
Iacobazzi V; Convertini P; Infantino V; Scarcia P; Todisco S; Palmieri F
Biochem Biophys Res Commun; 2009 Oct; 388(4):643-7. PubMed ID: 19665003
[TBL] [Abstract][Full Text] [Related]
39. Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptor-alpha activators.
Han SH; Quon MJ; Koh KK
Hypertension; 2005 Nov; 46(5):1086-92. PubMed ID: 16230515
[TBL] [Abstract][Full Text] [Related]
40. PPARalpha in atherosclerosis and inflammation.
Zandbergen F; Plutzky J
Biochim Biophys Acta; 2007 Aug; 1771(8):972-82. PubMed ID: 17631413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
